Get reimbursed for COVID-19 testing and treatment of uninsured individuals.     Learn more »

RCORP Neonatal Abstinence Syndrome

The purpose of RCORP-NAS is to reduce the incidence and impact of Neonatal Abstinence Syndrome (NAS) in rural communities by improving systems of care, family supports, and social determinants of health.

RCORP-NAS award recipients will receive up to $500,000 over a three-year period of performance to conduct a combination of prevention, treatment, and recovery activities designed to improve systems of care, family supports, and social determinants of health.

Additionally, award recipients will develop plans to sustain their services beyond the period of performance.

While the focus of RCORP-NAS is primarily opioid use disorder (OUD), applicants may also choose to address additional substances of concern or substance use disorders (SUDs) among the target population. The target population is pregnant women, mothers, and women of childbearing age who have a history of, or who are at risk for, SUD/OUD and their children, families, and caregivers who reside in rural areas.

Applicant Resources

Grant Recipients

 

Date Last Reviewed:  September 2020


Contact Us

Questions about HRSA's efforts to combat the opioid epidemic in rural communities? Email us.